These findings identify the CD153-CD30 interaction as a pivotal regulator of age-dependent TLT formation and suggest that targeting CD153/CD30 signaling may be a valuable strategy for the prevention and treatment of kidney diseases in the elderly. The gene discussed is TNFSF8; the disease is kidney disorder.